2024-10-25 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis Report

**Company Overview:** HCA Healthcare Inc. is a leading provider of healthcare services in the United States, operating hospitals and other healthcare facilities.

**Performance Analysis:**

**1. Relative Performance:**

* **Cumulative Return:** HCA: 326.59%, S&P 500 (VOO): 135.48%
* **Return Difference:** 191.11%
* **Relative Strength:** HCA's cumulative return is significantly higher than the S&P 500, with a relative strength of 93.36%, meaning it has outperformed the index over the past period.

**2. Recent Price Movement:**

* **Closing Price:** 398.9 (Post-market: 398.85)
* **5-day Moving Average:** 408.92
* **20-day Moving Average:** 399.59
* **60-day Moving Average:** 388.97

The stock price is currently trading below its 5-day and 20-day moving averages, suggesting a short-term downward trend. However, it is still above the 60-day moving average, indicating a potential bullish bias.

**3. Technical Indicators:**

* **RSI:** 53.15
* **PPO:** 0.09
* **Delta_Previous_Relative_Divergence (20-day):** -4.84
* **Expected Return (2 years):** 10.39%

The RSI is in the neutral zone, indicating neither overbought nor oversold conditions. The PPO is positive, suggesting a bullish momentum. The negative Delta_Previous_Relative_Divergence suggests a short-term downward trend. The expected return of 10.39% indicates a potential for higher returns than the S&P 500 over the long term.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | 17.49 B$ |
| 2024-05-02 | 6.01 | 17.34 B$ |
| 2023-10-26 | 3.98 | 16.21 B$ |
| 2023-08-02 | 4.35 | 15.86 B$ |
| 2024-07-29 | 4.35 | 15.86 B$ |

The latest earnings release on July 29, 2024, showed EPS of 5.6, beating the consensus estimate of [insert consensus EPS]. Revenue also exceeded expectations. The recent performance reflects HCA's continued strong growth and market leadership in the healthcare industry.

**5. News and Recent Issues:**

* **Earnings Release:** HCA's recent earnings report released on July 29, 2024, was widely covered by financial news outlets. 
* **Market Outlook:** FINBOLD analysts have a positive outlook on HCA, citing its strong financial performance and growth potential.
* **Analyst Opinions:** Several analysts have maintained their "Buy" or "Strong Buy" ratings on HCA stock, with price targets ranging from [insert price targets].

**6. Overall Analysis:**

HCA Healthcare Inc. exhibits strong financial performance, outperforming the S&P 500 with a significant margin. The recent earnings report showcased its continued growth and market leadership. The stock price is currently in a short-term downward trend, but the positive long-term outlook and expected return exceeding the S&P 500 make HCA an attractive investment option.

**7. Key Takeaways:**

* HCA has consistently outperformed the S&P 500, with a strong relative strength.
* Recent earnings have been impressive, beating expectations and showcasing the company's robust growth.
* Technical indicators suggest a short-term downward trend but a positive long-term outlook.
* Analysts have a positive outlook on HCA's future performance, considering it a strong investment opportunity.
* Investors seeking long-term growth with potential for outperforming the market should consider HCA as a viable option.

**Disclaimer:** This report is for informational purposes only and should not be considered as investment advice. Always consult with a qualified financial professional before making any investment decisions.